Anthony Quinn

Anthony Quinn

Plus aucun poste en cours
64 ans
Health Technology
Consumer Services
Process Industries

Profil

Anthony G.
Quinn
worked as Head-Clinical Research & Exploratory Development at Roche Palo Alto LLC from 2005 to 2009.
Served as Chief Medical Officer & Executive Vice President at Synageva BioPharma Corp.
from 2014 to 2015.
Held the position of President, Chief Executive Officer & Director at Spyre Therapeutics, Inc. from 2018 to 2022.
Acted as Independent Director at Kaleido Biosciences, Inc. from 2016 to 2022 and at Generation Bio Co. from 2017 to 2026.
Worked as Director-Experimental Medicine at AstraZeneca PLC.
Held roles as Principal at Charnwood Group, and Professor at London School of Hygiene & Tropical Medicine and St Bartholomew's Hospital Medical College.
Education includes undergraduate and graduate degrees from the University of Dundee conferred in 1982 and 1985, respectively, and a doctorate from Newcastle University conferred in 1994.

Anciens postes connus de Anthony Quinn

SociétésPosteFin
GENERATION BIO CO. Directeur/Membre du Conseil 06/02/2026
SPYRE THERAPEUTICS, INC. Directeur Général 24/08/2022
KALEIDO BIOSCIENCES, INC. Directeur/Membre du Conseil 01/06/2022
SYNAGEVA BIOPHARMA CORP Directeur Technique/Scientifique/R&D 01/06/2015
Corporate Officer/Principal 01/08/2009
Voir l'expérience en détail de Anthony Quinn

Formation de Anthony Quinn

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Process Industries

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Anthony Quinn
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT